📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Harnessing natural killer cell effector function against cancer. (2024)

First Author: Blunt MD

Attributed to: Targeting natural killer cell receptors for immunotherapeutic benefit funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1093/immadv/ltad031

PubMed Identifier: 38223411

Publication URI: http://europepmc.org/abstract/MED/38223411

Type: Journal Article/Review

Volume: 4

Parent Publication: Immunotherapy advances

Issue: 1

ISSN: 2732-4303